Skip to main content
. 2018 Sep 18;62(3):108–112. doi: 10.3345/kjp.2018.06730

Table 2.

Case studies of patients with SSPE that could survive long term

Study Country Age at primary measles infection (mo) Age at diagnosis of SSPE (yr) Duration of improvement (yr) Treatment F/U (yr) Result
Barraclough [2] (1983) UK 15 15 5 Transfer factor (8 times for 4 months) 9 Death
Miyazaki et al. [5] (2005) Japan Unknown 8 7-8 Intrathecal INF-α (1×106 IU/wk for 11 years) 19 Alive akinetic mutism

SSPE, subacute sclerosing panencephalitis; IFN, interferon.